Evome Medical Technologies Inc. (TSXV:EVMT)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
TSXV:EVMT Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Feb '22 Feb 28, 2022 | Dec '21 Dec 31, 2021 | Feb '21 Feb 28, 2021 | 2020 - 2016 |
| Operating Revenue | 48.34 | 62.63 | 40.31 | 18.31 | 15.12 | 0.15 | Upgrade
|
| Other Revenue | - | - | - | - | - | -0.18 | Upgrade
|
| Revenue | 48.34 | 62.63 | 40.31 | 18.31 | 15.12 | -0.03 | Upgrade
|
| Revenue Growth (YoY) | -16.32% | 55.35% | 120.15% | 21.08% | - | - | Upgrade
|
| Cost of Revenue | 32 | 40.09 | 27.64 | 12.35 | 10.7 | - | Upgrade
|
| Gross Profit | 16.34 | 22.53 | 12.67 | 5.96 | 4.42 | -0.03 | Upgrade
|
| Selling, General & Admin | 17.94 | 23.55 | 13.68 | 5.73 | 5.06 | 0.99 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.86 | 1.48 | 1.12 | 0.45 | 0.41 | - | Upgrade
|
| Operating Expenses | 21.84 | 28.05 | 15.85 | 6.57 | 5.82 | 0.99 | Upgrade
|
| Operating Income | -5.49 | -5.52 | -3.18 | -0.61 | -1.4 | -1.02 | Upgrade
|
| Interest Expense | -2.98 | -2.64 | -0.71 | -0.39 | -0.37 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | -0.23 | 0.02 | 0.02 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 3.81 | 5.57 | -12.32 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.67 | -2.59 | -16.44 | -0.98 | -1.74 | -1.02 | Upgrade
|
| Impairment of Goodwill | -10.95 | -10.23 | - | -5.52 | - | - | Upgrade
|
| Asset Writedown | -3.3 | -3.28 | - | - | - | - | Upgrade
|
| Other Unusual Items | -4.13 | 0.56 | -6.39 | 2.03 | -3.25 | -1.64 | Upgrade
|
| Pretax Income | -23.51 | -15.55 | -22.84 | -4.47 | -4.99 | -2.67 | Upgrade
|
| Income Tax Expense | 0.02 | 0.06 | -3.76 | -0.1 | 0 | - | Upgrade
|
| Earnings From Continuing Operations | -23.53 | -15.6 | -19.08 | -4.37 | -4.99 | -2.67 | Upgrade
|
| Net Income | -23.53 | -15.6 | -19.08 | -4.37 | -4.99 | -2.67 | Upgrade
|
| Net Income to Common | -23.53 | -15.6 | -19.08 | -4.37 | -4.99 | -2.67 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 73 | 55 | 44 | 43 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 73 | 55 | 44 | 43 | 34 | Upgrade
|
| Shares Change (YoY) | 28.35% | 33.97% | 25.70% | 1.90% | 26.68% | 0.03% | Upgrade
|
| EPS (Basic) | -0.27 | -0.21 | -0.35 | -0.10 | -0.12 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.27 | -0.21 | -0.35 | -0.10 | -0.12 | -0.08 | Upgrade
|
| Free Cash Flow | 5.37 | -1.12 | -1.76 | -3.76 | -4.03 | -0.98 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.01 | -0.03 | -0.09 | -0.09 | -0.03 | Upgrade
|
| Gross Margin | 33.80% | 35.98% | 31.44% | 32.56% | 29.24% | - | Upgrade
|
| Operating Margin | -11.37% | -8.82% | -7.89% | -3.32% | -9.22% | - | Upgrade
|
| Profit Margin | -48.68% | -24.91% | -47.32% | -23.88% | -33.01% | - | Upgrade
|
| Free Cash Flow Margin | 11.11% | -1.79% | -4.37% | -20.53% | -26.62% | - | Upgrade
|
| EBITDA | -3.65 | -3.04 | -1.75 | 0.04 | -0.8 | -0.97 | Upgrade
|
| EBITDA Margin | -7.55% | -4.85% | -4.35% | 0.22% | -5.29% | - | Upgrade
|
| D&A For EBITDA | 1.84 | 2.48 | 1.43 | 0.65 | 0.59 | 0.05 | Upgrade
|
| EBIT | -5.49 | -5.52 | -3.18 | -0.61 | -1.4 | -1.02 | Upgrade
|
| EBIT Margin | -11.37% | -8.82% | -7.89% | -3.32% | -9.22% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | - | -0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.